AAPL329.40-9.00 (-2.66%) ▼|ABBV263.29-2.99 (-1.12%) ▼|ABT100.95-0.03 (-0.03%) ▼|ACN177.12+2.65 (+1.52%) ▲|ADBE233.17+2.16 (+0.94%) ▲|AMAT512.01+25.25 (+5.19%) ▲|AMD607.57-0.30 (-0.05%) ▼|AMGN423.64+5.51 (+1.32%) ▲|AMT167.35-0.65 (-0.39%) ▼|AMZN246.67+0.52 (+0.21%) ▲|AVGO355.10+5.53 (+1.58%) ▲|AXP305.40-0.93 (-0.30%) ▼|BA187.68+3.29 (+1.78%) ▲|BAC54.96-0.51 (-0.92%) ▼|BKNG162.34-1.53 (-0.93%) ▼|BLK1,067.94-3.31 (-0.31%) ▼|BMY62.86-1.02 (-1.60%) ▼|BNY146.98-1.46 (-0.98%) ▼|BRK-B502.35-0.74 (-0.15%) ▼|C130.80-0.51 (-0.39%) ▼|CAT826.64+6.69 (+0.82%) ▲|CL86.46-0.06 (-0.07%) ▼|CMCSA21.60-0.19 (-0.87%) ▼|COF196.46+0.00 (+0.00%) ▲|COP125.44-0.60 (-0.48%) ▼|COST924.59+1.67 (+0.18%) ▲|CRM225.31-1.96 (-0.86%) ▼|CSCO106.94+0.20 (+0.19%) ▲|CVS87.10-0.75 (-0.85%) ▼|CVX204.38-1.99 (-0.96%) ▼|DE680.50-9.09 (-1.32%) ▼|DHR226.11-1.22 (-0.54%) ▼|DIS105.41-0.18 (-0.17%) ▼|DUK114.21+0.80 (+0.71%) ▲|EMR157.24-2.15 (-1.35%) ▼|FDX287.47-2.18 (-0.75%) ▼|GD332.34-1.82 (-0.54%) ▼|GE317.89-0.35 (-0.11%) ▼|GEV962.49+12.72 (+1.34%) ▲|GILD151.28-0.93 (-0.61%) ▼|GM80.47-0.17 (-0.21%) ▼|GOOG337.32-1.84 (-0.54%) ▼|GOOGL340.92-1.83 (-0.53%) ▼|GS916.24-0.04 (0.00%) ▼|HD288.04-1.85 (-0.64%) ▼|HON210.13-1.39 (-0.66%) ▼|IBM219.99-0.68 (-0.31%) ▼|INTC115.93-0.10 (-0.09%) ▼|INTU268.03-1.37 (-0.51%) ▼|ISRG412.18-2.61 (-0.63%) ▼|JNJ267.57-4.38 (-1.61%) ▼|JPM334.98-1.61 (-0.48%) ▼|KO86.84-0.34 (-0.39%) ▼|LIN473.37+1.33 (+0.28%) ▲|LLY1,184.63-0.15 (-0.01%) ▼|LMT512.21-5.89 (-1.14%) ▼|LOW187.26-0.40 (-0.21%) ▼|LRCX323.86+9.39 (+2.99%) ▲|MA563.58-4.68 (-0.82%) ▼|MCD233.98+0.38 (+0.16%) ▲|MDLZ59.32-0.86 (-1.43%) ▼|MDT87.09-2.41 (-2.69%) ▼|META738.79+23.17 (+3.24%) ▲|MMM168.49-0.99 (-0.58%) ▼|MO68.72-0.41 (-0.59%) ▼|MRK149.28+0.59 (+0.40%) ▲|MS192.76-0.88 (-0.45%) ▼|MSFT508.96-0.26 (-0.05%) ▼|MU1,065.08+11.10 (+1.05%) ▲|NEE75.89+0.40 (+0.53%) ▲|NFLX70.30+1.07 (+1.55%) ▲|NKE35.84-0.55 (-1.51%) ▼|NOW129.94-1.51 (-1.15%) ▼|NVDA227.21-1.65 (-0.72%) ▼|ORCL137.79+5.19 (+3.91%) ▲|PEP128.69+0.19 (+0.15%) ▲|PFE28.72+0.00 (+0.00%) ▲|PG148.32-0.71 (-0.48%) ▼|PLTR186.97-0.51 (-0.27%) ▼|PM193.90+0.14 (+0.07%) ▲|QCOM184.10-3.38 (-1.80%) ▼|RTX186.94-0.72 (-0.38%) ▼|SBUX95.43+0.16 (+0.17%) ▲|SCHW99.10+0.80 (+0.81%) ▲|SO83.45+1.10 (+1.34%) ▲|SPG204.28-0.25 (-0.12%) ▼|T24.48-0.42 (-1.69%) ▼|TMO679.61+1.01 (+0.15%) ▲|TMUS162.98-3.47 (-2.08%) ▼|TSLA352.84-4.61 (-1.29%) ▼|TXN281.69+3.38 (+1.21%) ▲|UBER69.36+1.20 (+1.76%) ▲|UNH374.94-2.89 (-0.76%) ▼|UNP274.15+0.05 (+0.02%) ▲|UPS93.93-0.32 (-0.34%) ▼|USB58.14-0.64 (-1.09%) ▼|V365.88-1.86 (-0.51%) ▼|VZ45.98-0.70 (-1.50%) ▼|WFC80.48-0.33 (-0.41%) ▼|WMT106.80-1.93 (-1.78%) ▼|XOM161.35-1.17 (-0.72%) ▼|AAPL329.40-9.00 (-2.66%) ▼|ABBV263.29-2.99 (-1.12%) ▼|ABT100.95-0.03 (-0.03%) ▼|ACN177.12+2.65 (+1.52%) ▲|ADBE233.17+2.16 (+0.94%) ▲|AMAT512.01+25.25 (+5.19%) ▲|AMD607.57-0.30 (-0.05%) ▼|AMGN423.64+5.51 (+1.32%) ▲|AMT167.35-0.65 (-0.39%) ▼|AMZN246.67+0.52 (+0.21%) ▲|AVGO355.10+5.53 (+1.58%) ▲|AXP305.40-0.93 (-0.30%) ▼|BA187.68+3.29 (+1.78%) ▲|BAC54.96-0.51 (-0.92%) ▼|BKNG162.34-1.53 (-0.93%) ▼|BLK1,067.94-3.31 (-0.31%) ▼|BMY62.86-1.02 (-1.60%) ▼|BNY146.98-1.46 (-0.98%) ▼|BRK-B502.35-0.74 (-0.15%) ▼|C130.80-0.51 (-0.39%) ▼|CAT826.64+6.69 (+0.82%) ▲|CL86.46-0.06 (-0.07%) ▼|CMCSA21.60-0.19 (-0.87%) ▼|COF196.46+0.00 (+0.00%) ▲|COP125.44-0.60 (-0.48%) ▼|COST924.59+1.67 (+0.18%) ▲|CRM225.31-1.96 (-0.86%) ▼|CSCO106.94+0.20 (+0.19%) ▲|CVS87.10-0.75 (-0.85%) ▼|CVX204.38-1.99 (-0.96%) ▼|DE680.50-9.09 (-1.32%) ▼|DHR226.11-1.22 (-0.54%) ▼|DIS105.41-0.18 (-0.17%) ▼|DUK114.21+0.80 (+0.71%) ▲|EMR157.24-2.15 (-1.35%) ▼|FDX287.47-2.18 (-0.75%) ▼|GD332.34-1.82 (-0.54%) ▼|GE317.89-0.35 (-0.11%) ▼|GEV962.49+12.72 (+1.34%) ▲|GILD151.28-0.93 (-0.61%) ▼|GM80.47-0.17 (-0.21%) ▼|GOOG337.32-1.84 (-0.54%) ▼|GOOGL340.92-1.83 (-0.53%) ▼|GS916.24-0.04 (0.00%) ▼|HD288.04-1.85 (-0.64%) ▼|HON210.13-1.39 (-0.66%) ▼|IBM219.99-0.68 (-0.31%) ▼|INTC115.93-0.10 (-0.09%) ▼|INTU268.03-1.37 (-0.51%) ▼|ISRG412.18-2.61 (-0.63%) ▼|JNJ267.57-4.38 (-1.61%) ▼|JPM334.98-1.61 (-0.48%) ▼|KO86.84-0.34 (-0.39%) ▼|LIN473.37+1.33 (+0.28%) ▲|LLY1,184.63-0.15 (-0.01%) ▼|LMT512.21-5.89 (-1.14%) ▼|LOW187.26-0.40 (-0.21%) ▼|LRCX323.86+9.39 (+2.99%) ▲|MA563.58-4.68 (-0.82%) ▼|MCD233.98+0.38 (+0.16%) ▲|MDLZ59.32-0.86 (-1.43%) ▼|MDT87.09-2.41 (-2.69%) ▼|META738.79+23.17 (+3.24%) ▲|MMM168.49-0.99 (-0.58%) ▼|MO68.72-0.41 (-0.59%) ▼|MRK149.28+0.59 (+0.40%) ▲|MS192.76-0.88 (-0.45%) ▼|MSFT508.96-0.26 (-0.05%) ▼|MU1,065.08+11.10 (+1.05%) ▲|NEE75.89+0.40 (+0.53%) ▲|NFLX70.30+1.07 (+1.55%) ▲|NKE35.84-0.55 (-1.51%) ▼|NOW129.94-1.51 (-1.15%) ▼|NVDA227.21-1.65 (-0.72%) ▼|ORCL137.79+5.19 (+3.91%) ▲|PEP128.69+0.19 (+0.15%) ▲|PFE28.72+0.00 (+0.00%) ▲|PG148.32-0.71 (-0.48%) ▼|PLTR186.97-0.51 (-0.27%) ▼|PM193.90+0.14 (+0.07%) ▲|QCOM184.10-3.38 (-1.80%) ▼|RTX186.94-0.72 (-0.38%) ▼|SBUX95.43+0.16 (+0.17%) ▲|SCHW99.10+0.80 (+0.81%) ▲|SO83.45+1.10 (+1.34%) ▲|SPG204.28-0.25 (-0.12%) ▼|T24.48-0.42 (-1.69%) ▼|TMO679.61+1.01 (+0.15%) ▲|TMUS162.98-3.47 (-2.08%) ▼|TSLA352.84-4.61 (-1.29%) ▼|TXN281.69+3.38 (+1.21%) ▲|UBER69.36+1.20 (+1.76%) ▲|UNH374.94-2.89 (-0.76%) ▼|UNP274.15+0.05 (+0.02%) ▲|UPS93.93-0.32 (-0.34%) ▼|USB58.14-0.64 (-1.09%) ▼|V365.88-1.86 (-0.51%) ▼|VZ45.98-0.70 (-1.50%) ▼|WFC80.48-0.33 (-0.41%) ▼|WMT106.80-1.93 (-1.78%) ▼|XOM161.35-1.17 (-0.72%) ▼|
18.1 C
New York
Wednesday, September 30, 2026

Tag: 1

Anti-CCR8 Antibodies Market to Witness Remarkable Growth Trajectory During the Forecast Period (2025-2040) Across 7MM | DelveInsight

The anti-CCR8 antibodies market holds potential in addressing unmet needs across inflammatory and cancerous diseases. The anti-CCR8 inhibitor market is expected to witness substantial...

Anti-CCR8 Antibodies Market to Witness Remarkable Growth Trajectory During the Forecast Period (2025-2040) Across 7MM | DelveInsight

The anti-CCR8 antibodies market holds potential in addressing unmet needs across inflammatory and cancerous diseases. The anti-CCR8 inhibitor market is expected to witness substantial...

Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

SAN DIEGO, June 26, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced the closing of its underwritten public offering of 9,147,727 shares of its common stock, including the exercise in full by the underwriters of their option to purchase an additional 1,193,181 shares, at a price to the public of $44.00 per share. The gross proceeds to Cidara from the offering, before deducting underwriting discounts and commissions and offering expenses, were $402.5 million. All of the shares in the offering were sold by Cidara.

CK Mondavi Unveils Bold New Label Designed by Alycia Mondavi

Labels offer nutritional transparency and a fresh look rooted in family legacy NAPA, Calif., June 26, 2025 /PRNewswire/ -- CK Mondavi, the iconic family-owned winery...

Stack Capital Group Inc. Announces Results of Its 2025 Annual General Meeting & Election of Directors

Stack Capital Group Inc. is pleased to announce that at its annual meeting of shareholders, held virtually today, its four director nominees were elected.

Westport to Issue Q2 2025 Financial Results on August 11, 2025 and Provides an Update on the Divestment of the Light-Duty Segment

VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) -- Westport Fuel Systems Inc. (TSX: WPRT / Nasdaq: WPRT) (“Westport” or “The Company”) announces that the Company will release Q2 2025 financial results on Monday, August 11, 2025, after market close. A conference call and webcast to discuss the financial results and other corporate developments will be held on Tuesday, August 12, 2025.

Rogers Communications 2Q25 Investment Community Teleconference July 23, 2025 at 8:00 a.m. ET

TORONTO, June 26, 2025 (GLOBE NEWSWIRE) -- Rogers Communications Inc. (TSX: RCI.A and RCI.B) (NYSE: RCI) plans to release its second quarter 2025 financial results on Wednesday, July 23, 2025, before North American financial markets open. The results will be distributed by newswire and posted at investors.rogers.com. Rogers’ management will host its quarterly teleconference with the investment community to discuss the results and outlook at 8:00 a.m. ET.

Eisenhower Fellowships Names 2025 USA Fellows

PHILADELPHIA, June 26, 2025 /PRNewswire/ -- Eisenhower Fellowships (EF) has selected nine exceptional young American leaders from diverse professional fields for its prestigious 2025...

4Front Ventures Provides Update on Receivership Proceedings and Board Resignations

PHOENIX, June 26, 2025 /PRNewswire/ - 4Front Ventures Corp. ("4Front" or the "Company") (CSE: FFNT) (OTC: FFNTF), a vertically integrated cannabis operator, provides an update...

Located within the new Hard Rock Hotel & Casino Ottawa – QUÉBEC-BASED SCÉNO PLUS DESIGNS THE NEW HARD ROCK LIVE OTTAWA THEATRE

MONTREAL, June 26, 2025 /CNW/ - Internationally acclaimed Québec firm Scéno Plus, renowned for designing iconic performance venues — from The Colosseum at Caesars Palace...

ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP

LEIDEN, Netherlands & CAMBRIDGE, Mass., June 26, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced the submission of a Clinical Trial Application (CTA) to the European Medicines Agency (EMA) to initiate a Phase 1 clinical trial of its lead pipeline program AX-0810 targeting NTCP, a liver cell protein that transports bile acids into cells. AX-0810 is an investigational ADAR-mediated RNA editing oligonucleotide (EON) designed to selectively modulate NTCP function by reducing toxic bile acid accumulation in the liver, potentially mitigating inflammation, fibrosis, and progression toward liver failure, which are common in cholestatic diseases.

Black Hills Corp. Releases 2024 Corporate Sustainability Report Highlighting Progress on Climate Goals and Innovation

RAPID CITY, S.D., June 26, 2025 (GLOBE NEWSWIRE) -- Black Hills Corp. (NYSE: BKH) today announced the release of its 2024 Corporate Sustainability Report, showcasing the company’s continued commitment to a resilient energy future through safe, reliable and cost-effective energy solutions.

Coveo Named a Leader in the 2025 Gartner® Magic Quadrant™ for Search and Product Discovery

Coveo Named a Leader for the Second Consecutive Year MONTREAL and SAN FRANCISCO, June 26, 2025 /PRNewswire/ - Coveo, the leader in AI-Relevance, delivering best-in-class...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTags1